Clinical Trials Directory

Trials / Conditions / Myeloproliferative Disease

Myeloproliferative Disease

12 registered clinical trials studyying Myeloproliferative Disease — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic M
NCT07518940
Carmen FavaN/A
RecruitingEvaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response
NCT05553873
University of Milano Bicocca—
RecruitingUnveiling the Germline Predisposition to Myeloproliferative Neoplasms
NCT07204392
Fondazione IRCCS Policlinico San Matteo di Pavia—
Active Not RecruitingAutoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (M
NCT07204366
Fondazione IRCCS Policlinico San Matteo di Pavia—
CompletedRetrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions
NCT02308787
Terumo BCT—
UnknownA Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.
NCT01884974
Carmel Medical Center—
TerminatedComparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylax
NCT01749111
Hospital Israelita Albert EinsteinPhase 3
CompletedBone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
NCT01758042
Massachusetts General HospitalN/A
CompletedSafety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute L
NCT01167166
Traws Pharma, Inc.Phase 1 / Phase 2
UnknownEvaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT01800643
Hospital Israelita Albert EinsteinPhase 2 / Phase 3
CompletedImmunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
NCT01394640
Paolo Corradini—
CompletedCorrelative Biomarker Study in Patients With Myeloproliferative Disorders
NCT00665067
Icahn School of Medicine at Mount Sinai—